Skip to content

Comparison of ESP with peri tubal infiltration of ropivacaine for post operative analgesia in PCNL surgeries.

Comparison Of Peritubal Infiltration and USG guided Erector spinae Plane block for Post operative Analgesia in Percutaneous Nephrolithotomy -A prospective randomised controlled study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097196
Enrollment
60
Registered
2025-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

Intervention1: Group E -USG guided erector spinae block with 20ml of 0.375% 20 ml Ropivacaine Group L- peritubal infiltration of 20ml 0.375% bupivacaine.: Erector spinae block is given with 0.375% 20

Sponsors

Dr D Tulja Bhavani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA-1and ASA-2patients of either sex 2. Patients of age between 18-60years of age 3. Patients posted for elective percutaneous nephrolithotomy under general Anaesthesia

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2.Patients with known hypersensitivity to known local Anesthetic drug 3.Patients with bleeding diathesis , uncontrolled diabetes mellitus and severe hepatorenal disease . 4. Patients with epilepsy and mentally unstable patients 5.Pregnant and lactating women 6. Patients on chronic analgesic therapy and anticoagulants. 7. Patients with cardio respiratory, neurological or psychiatric illness. 8. Renal stones which require more than one puncture , supra coastal puncture intraoperative excessive bleeding 9.Surgical time more than 3hours 10.BMI morethan 35Kg/m2

Design outcomes

Primary

MeasureTime frame
To compare the need for first rescue analgesia in both groups- in patients receiving 0.375% Ropivacaine vs patients receiving peri tubal infiltration.Timepoint: at 0,2,4,6,8,10,12,16,18 and 24hours in both groups.

Secondary

MeasureTime frame
to compare the total analgesic consumptionTimepoint: at 0,2,4,6,8,10,12,16,18 till 24 hours

Countries

India

Contacts

Public ContactDr Jyoti Petkar

Rajarajeswari medical college and hospital

jokiran2009@gmail.com7726899533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026